Panel Discussion: Making Clinical Trial Participation Diverse and Accessible | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Panel Discussion: Making Clinical Trial Participation Diverse and Accessible

  1. Home
Panel Discussion: Making Clinical Trial Participation Diverse and Accessible

To view the full version of this video, please tell us more about yourself. »

Presenter(s): 
Shaalan Beg, MD, MBA, FASCO
Maria Velez, MD, MS
Ashley Woods, MD
Topic(s): 
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Fri, 11/08/2024 - 9:00am (EST)

This symposium session highlights key strategies for fostering inclusivity in clinical research. Presentations cover the benefits and challenges of decentralized clinical trials, the critical role of translating consent documents for patients with limited English proficiency, and FDA initiatives to promote diversity. This video provides actionable insights into creating equitable opportunities for all participants in clinical trials.